Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;109(4):415-422.
doi: 10.1007/s00223-021-00859-8. Epub 2021 May 15.

Psychometric Properties of the Chinese Version of the Sarcopenia and Quality of Life, a Quality of Life Questionnaire Specific for Sarcopenia

Xiaofeng Le #  1 , Yao Wei #  2 , Dingjun Hao  3 , Lequn Shan  1 , Xiaoli Li  2 , Qifang Shi  4 , Ding Ding  5 , Xiang Cheng  6 , Hwee Ling Eileen Lim  7 , Bao Yi Ng  8
Affiliations

Psychometric Properties of the Chinese Version of the Sarcopenia and Quality of Life, a Quality of Life Questionnaire Specific for Sarcopenia

Xiaofeng Le et al. Calcif Tissue Int. 2021 Oct.

Abstract

A quality of life questionnaire specific to sarcopenia (SarQoL®) was successfully developed. There is a huge demand for translation and validation in Chinese. The aim of this study was to translate the SarQoL® into Chinese and investigate its psychometric properties. The translation and cross-cultural adaptation process recommended by the developers of the initial questionnaire was followed. A total of 159 participants were investigated. The translation process consists of five steps: (1) two bilinguals independently translate initial English to Chinese; (2) synthesize the two translations into one; (3) backward translations; (4) expert committee review and (5) test of the pre-final version. The validation consists of three parts: (1) validity (discriminative power, construct validity); (2) reliability (internal consistency, test-retest reliability) and (3) floor and ceiling effects. There was no difficulty in translation process. Regarding the validity, good discriminant validity {quality of life for sarcopenic subjects [35.56 (29.73-42.70)] vs. non-sarcopenic ones [73.22 (60.09-82.90)], p < 0.001} and consistent construct validity [high correlations (spearman's r) of SarQoL® with generic Short Form-36 version 2 questionnaire (0.250 to 0.824) and EuroQoL-5-Dimension questionnaire (- 0.114 to - 0.823)] were found in SarQoL®. Regarding reliability, high internal consistency (Cronbach's alpha coefficient was 0.867) and excellent test-retest reliability (intraclass coefficient correlation was 0.997, 95% CI 0.994-0.998) were found. No ceiling/floor effect was reflected. A valid SarQoL® questionnaire is now available for Chinese population. It can provide a better understanding of the sarcopenia disease burden and serve as a therapeutic outcome indicator in research.

Keywords: Chinese SarQoL®; Quality of life; Questionnaire; Sarcopenia.

PubMed Disclaimer

References

    1. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21(3):300-307 e302. https://doi.org/10.1016/j.jamda.2019.12.012 - DOI
    1. Phillips A, Strobl R, Vogt S, Ladwig KH, Thorand B, Grill E (2017) Sarcopenia is associated with disability status-results from the KORA-Age study. Osteoporos Int 28(7):2069–2079. https://doi.org/10.1007/s00198-017-4027-y - DOI - PubMed
    1. Tang TC, Hwang AC, Liu LK, Lee WJ, Chen LY, Wu YH, Huang CY, Hung CH, Wang CJ, Lin MH, Peng LN, Chen LK (2018) FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in taiwan: results from I-Lan Longitudinal Aging Study. J Gerontol A Biol Sci Med Sci 73(6):828–834. https://doi.org/10.1093/gerona/glx148 - DOI
    1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older P, the Extended Group for E (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31. https://doi.org/10.1093/ageing/afy169 - DOI
    1. Wang H, Hai S, Liu Y, Cao L, Liu Y, Liu P, Zhou J, Yang Y, Dong B (2018) Association between depressive symptoms and sarcopenia in older Chinese community-dwelling individuals. Clin Interv Aging 13:1605–1611. https://doi.org/10.2147/CIA.S173146 - DOI - PubMed - PMC

LinkOut - more resources